Ian Gourley
Hoofd Techniek/Wetenschap/O&O bij IMMUNOVANT, INC.
Actieve functies van Ian Gourley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IMMUNOVANT, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
Loopbaan van Ian Gourley
Eerdere bekende functies van Ian Gourley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - | - |
Opleiding van Ian Gourley
| Queen's University of Belfast | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 3 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Beurs
- Insiders
- Ian Gourley
- Ervaring